“Diabetes is on the rise and now is the time to act” …

“Diabetes is on the rise and now is the time to act” – ADLDi initiates an awareness drive on diabetes and obesity


Islamabad (Muhammad Yasir) Alliance for Diabetes and Liver Diseases (ADLDi) announced the launch of Fit 4 Health awareness campaign at an event in Islamabad.

The event gathered the principals and faculty members of schools from Islamabad and Rawalpindi, where they were briefed about the importance of inculcating the concept of healthy living among school children from young age.  Addressing the event, Chairperson ADLDi, Prof. Dr Saleem Qureshi said, “Diabetes is a situation that needs to be addressed urgently as it poses a great burden on the economy of Pakistan. An initiative like Fit 4 Health which focuses towards creating awareness among the youth, is certainly a step in the right direction”. The co-chair ADLDi, Dr Musarrat Iqbal said that the objective of this collective initiative is to create awareness among students about adopting a healthy lifestyle from an early age to address the increasing trend of diabetes & obesity. Lifestyle modification, physical activity and healthy diet can delay or prevent onset of type 2 diabetes. We are already a little late”, she said.

Wasim Akram, Brand Ambassador for changing diabetes® in Pakistan, shared his experience with the audience, emphasizing on the importance of early diagnosis for better management of diabetes.  “Fit 4 Health” is running in collaboration with Novo Nordisk Pharma (Pvt) Ltd and endorsed by the Ministry of National Health Services Regulation and Coordination. Rashed Rafique Butt, Vice President and General Manager of Novo Nordisk Pharma (Pvt) Ltd was also present the event along with the Ambassador of Denmark to Pakistan, Mr Rolf M. Holmboe.

Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 42,200 people in 80 countries and markets its products in more than 170 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.